Business Description
Celularity Inc. is a New Jersey-based medical company founded in 1998 that develops treatments for aging and degenerative conditions using cells and tissues derived from human placentas. Its product pipeline targets diseases such as Crohn's disease, diabetic foot ulcers, muscular dystrophy, and osteoarthritis, while its commercial portfolio includes wound care and surgical products sold under several brand names. The company also runs a biobanking service through LifebankUSA, collecting and storing umbilical cord and placental material after birth, and works alongside partners including Regeneron Pharmaceuticals and Sorrento Therapeutics to advance its research.
